ArticleAntiviral therapy2014

Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study.

David A Wohl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.